Page last updated: 2024-12-08

manoyl oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

manoyl oxide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID518574
SCHEMBL ID16984745
MeSH IDM0451563

Synonyms (15)

Synonym
manoyl oxide
3-ethenyl-3,4a,7,7,10a-pentamethyldodecahydro-1h-benzo[f]chromene
STK058712
AKOS000621408
3-ethenyl-3,4a,7,7,10a-pentamethyl-2,5,6,6a,8,9,10,10b-octahydro-1h-benzo[f]chromene
AKOS022078851
3-ethenyldodecahydro-3,4a,7,7,10a-pentamethyl-1h-naphtho[2,1-b]pyran
19123-29-6
IGGWKHQYMAJOHK-UHFFFAOYSA-N
manool oxide
3,4a,7,7,10a-pentamethyl-3-vinyldodecahydro-1h-benzo[f]chromene #
8.alpha.,13-epoxylabd-14-ene
SCHEMBL16984745
Q67880189
1h-naphtho[2,1-b]pyran,3-e
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (15.00)29.6817
2010's17 (85.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.61 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]